These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3384664)

  • 1. [Localized neutrophilic eccrine hydradenitis in mitoxantrone therapy: a typical side-effect of cytostatic drugs].
    Burg G; Bieber T; Langecker P
    Hautarzt; 1988 Apr; 39(4):233-6. PubMed ID: 3384664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophilic eccrine hidradenitis in acute myelomonocytic leukemia.
    Katsanis E; Luke KH; Hsu E; Carpenter BF; Mantynen PR
    Am J Pediatr Hematol Oncol; 1987; 9(3):204-8. PubMed ID: 3479026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eccrine squamous syringometaplasia. A cutaneous sweat gland reaction in the histologic spectrum of 'chemotherapy-associated eccrine hidradenitis' and 'neutrophilic eccrine hidradenitis'.
    Hurt MA; Halvorson RD; Petr FC; Cooper JT; Friedman DJ
    Arch Dermatol; 1990 Jan; 126(1):73-7. PubMed ID: 2404465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line intra-arterial chemotherapy (IAC) with epirubicin and mitoxantrone in locally advanced breast cancer.
    Fiorentini G; Tsetis D; Bernardeschi P; Varveris C; Rossi S; Kalogeraki A; Athanasakis E; Dentico P; Kanellos P; Biancalani M; Almarashdah S; Zacharioudakis G; Saridaki Z; Chalkiadakis G; Xynos E; Zoras O
    Anticancer Res; 2003; 23(5b):4339-45. PubMed ID: 14666649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
    Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
    Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.
    Gisselbrecht C; Extra JM; Lotz JP; Devaux Y; Janvier M; Peny AM; Guillevin L; Bremond D; Delain M; Herbrecht R; Lepage E; Maraninchi D
    Bone Marrow Transplant; 1996 Nov; 18(5):857-63. PubMed ID: 8932837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
    Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK
    J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophilic eccrine hidradenitis. Evidence implicating bleomycin as a causative agent.
    Scallan PJ; Kettler AH; Levy ML; Tschen JA
    Cancer; 1988 Dec; 62(12):2532-6. PubMed ID: 2461249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report].
    Izumi M; Iino Y; Yokoe T; Inoue T; Yamada T; Kobayashi I; Andoh T; Yokota T; Iijima T; Morishita Y
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):265-8. PubMed ID: 8311500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
    Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
    Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery: in regards to Toledano et al. (Int J Radiat Oncol Biol Phys 2006;65:324-332).
    Munshi A; Jalali R
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):314; author reply 314-5. PubMed ID: 16904531
    [No Abstract]   [Full Text] [Related]  

  • 13. Syringoma-like eccrine sweat duct proliferation induced by radiation.
    Yoshii N; Kanekura T; Churei H; Kanzaki T
    J Dermatol; 2006 Jan; 33(1):36-9. PubMed ID: 16469082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. German GABG-4/EH-93-Study.
    Zander AR; Krüger W; Kröger N; Damon L; Königmann M; Berdel WE; Gieseking F; Schäfer-Eckart K; Möbus V; Frickhofen N; Wandt H; Illiger HJ; Metzner B; Kolbe K; Wörmann B; Trümper L; Huber C; Hossfeld DK; Maass H; Jonat W
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S24-5. PubMed ID: 8899165
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adjuvant chemotherapy with mitoxantrone, cyclophosphamide and 5-fluorouracil in breast neoplasms: therapeutic life].
    Genre D; Macquart-Moulin G; Bouscary ML; Viens P; Cowen D; Packer y Comyn I; Moatti JP; Maraninchi D
    Bull Cancer; 1997 Mar; 84(3):240-6. PubMed ID: 9207868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adriamycin, cyclophosphamide and vindesine (ACV) versus mitoxantrone, cyclophosphamide and vindesine (NCV) in advanced breast cancer.
    Janssens JP; Chin Y; Deleu M; Bonte J; Staelens Y
    Anticancer Res; 1993; 13(6B):2477-83. PubMed ID: 8135486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytostatic therapy in metastatic breast cancer].
    Rainer H; Lenzhofer R
    Wien Klin Wochenschr; 1984 Jun; 96(13):517-21. PubMed ID: 6548066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of advanced and relapsing breast cancer with a combination of paclitaxel and mitoxantrone. South-Central Hellenic Oncology Group.
    Panagos GE
    Semin Oncol; 1997 Feb; 24(1 Suppl 3):S17-21. PubMed ID: 9071335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophilic eccrine hidradenitis.
    Vion B; Alvero H
    Dermatologica; 1991; 183(1):70-2. PubMed ID: 1769425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate, mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer patients.
    Merlini L; Secondo V; Mammoliti S; Bellotti P; Castello C; Gallo L
    Anticancer Res; 1994; 14(3B):1423-6. PubMed ID: 8067717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.